The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

DIRECTOR DEALINGS: Verona Pharma Directors Buy Shares

Mon, 18th May 2015 14:03

LONDON (Alliance News) - Verona Pharma PLC Monday said a group of directors including Chairman David Ebsworth bought shares.

Details are as follows.

Director

Ordinary Shares Purchased

Date

Average Price (p)

Total interest in the Company

As a % of the total share capital

Dr. David Ebsworth

300,000

18/05/2015

3.50

3,579,774

0.35%

Dr. Jan-Anders Karlsson

135,000

15/05/2015

3.40

2,870,000

0.28%

Biresh Roy

150,000

18/05/2015

3.50

900,000

0.09%


Shares in the bio technology company were up 8.3% at 3.60 pence Monday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News
29 Oct 2020 19:09

IN BRIEF: Verona Pharma Says Third Quarter Loss Widens

IN BRIEF: Verona Pharma Says Third Quarter Loss Widens

22 Oct 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

21 Sep 2020 14:12

IN BRIEF: Verona Pharma To Delist From AIM But Remain On Nasdaq

IN BRIEF: Verona Pharma To Delist From AIM But Remain On Nasdaq

14 Sep 2020 13:13

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

24 Aug 2020 11:09

Verona Pharma Says Study Shows Ensifentrine Improves Lung Function

Verona Pharma Says Study Shows Ensifentrine Improves Lung Function

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.